Zobrazeno 1 - 10
of 726
pro vyhledávání: '"Selvan, N"'
Autor:
Vivek, P.1 (AUTHOR) vivekpsgped11@gmail.com, Muthu Selvan, N. B.2 (AUTHOR)
Publikováno v:
Electrical Engineering. Oct2023, Vol. 105 Issue 5, p2889-2908. 20p.
Publikováno v:
In Journal of Drug Delivery Science and Technology February 2020 55
Autor:
Ranjith, R., Renganathan, Vengudusamy, Chen, Shen-Ming, Selvan, N. Senthamizh, Rajam, P. Shameela
Publikováno v:
In Ceramics International July 2019 45(10):12926-12933
Autor:
Selvan, N., Williamson, Ritchie, Mariappa, D., Campbell, D.G., Gourlay, R., Ferenbach, A.T., Aristotelous, T., Hopkins-Navratilova, I., Trost, M., van Aalten, D.M.F.
Yes
Protein O-GlcNAcylation is a reversible post-translational modification of serines/threonines on nucleocytoplasmic proteins. It is cycled by the enzymes O-GlcNAc transferase (OGT) and O-GlcNAc hydrolase (O-GlcNAcase or OGA). Genetic approach
Protein O-GlcNAcylation is a reversible post-translational modification of serines/threonines on nucleocytoplasmic proteins. It is cycled by the enzymes O-GlcNAc transferase (OGT) and O-GlcNAc hydrolase (O-GlcNAcase or OGA). Genetic approach
Externí odkaz:
http://hdl.handle.net/10454/12133
Autor:
Rojsajjakul T; Department of Systems Pharmacology and Translational Therapeutics Perelman School of Medicine, Penn/CHOP Friedreich's Ataxia Center of Excellence, Center of Excellence in Environmental Toxicology, University of Pennsylvania, Philadelphia, PA, USA., Selvan N; LEXEO Therapeutics, Inc, New York, NY, USA., De B; Department of Genetic Medicine, Weill Cornell College of Medicine, New York, NY, USA., Rosenberg JB; Department of Genetic Medicine, Weill Cornell College of Medicine, New York, NY, USA., Kaminsky SM; Department of Genetic Medicine, Weill Cornell College of Medicine, New York, NY, USA., Sondhi D; Department of Genetic Medicine, Weill Cornell College of Medicine, New York, NY, USA., Janki P; LEXEO Therapeutics, Inc, New York, NY, USA., Crystal RG; Department of Genetic Medicine, Weill Cornell College of Medicine, New York, NY, USA., Mesaros C; Department of Systems Pharmacology and Translational Therapeutics Perelman School of Medicine, Penn/CHOP Friedreich's Ataxia Center of Excellence, Center of Excellence in Environmental Toxicology, University of Pennsylvania, Philadelphia, PA, USA., Khanna R; LEXEO Therapeutics, Inc, New York, NY, USA., Blair IA; Department of Systems Pharmacology and Translational Therapeutics Perelman School of Medicine, Penn/CHOP Friedreich's Ataxia Center of Excellence, Center of Excellence in Environmental Toxicology, University of Pennsylvania, Philadelphia, PA, USA. ianblair@upenn.edu.
Publikováno v:
Scientific reports [Sci Rep] 2024 Apr 10; Vol. 14 (1), pp. 8391. Date of Electronic Publication: 2024 Apr 10.
Publikováno v:
Journal of Electrical Engineering & Technology (19750102); Jan2024, Vol. 19 Issue 1, p31-44, 14p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Acta Scientific Orthopaedics. :61-65
Publikováno v:
Smart Grids and Microgrids. :273-294
Publikováno v:
IOP Conference Series: Earth & Environmental Science; 2022, Vol. 1100 Issue 1, p1-25, 25p